Logo image of 1AVAV.MI

AEROVIRONMENT INC (1AVAV.MI) Stock Fundamental Analysis

Europe - BIT:1AVAV - US0080731088 - Common Stock

242.8 EUR
+28.8 (+13.46%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1AVAV. 1AVAV was compared to 48 industry peers in the Aerospace & Defense industry. While 1AVAV seems to be doing ok healthwise, there are quite some concerns on its profitability. 1AVAV shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

1AVAV had positive earnings in the past year.
1AVAV had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1AVAV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: 1AVAV reported negative operating cash flow in multiple years.
1AVAV.MI Yearly Net Income VS EBIT VS OCF VS FCF1AVAV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

1AVAV has a Return On Assets of -0.80%. This is in the lower half of the industry: 1AVAV underperforms 78.26% of its industry peers.
1AVAV has a Return On Equity of -1.01%. This is in the lower half of the industry: 1AVAV underperforms 76.09% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.01%
ROIC N/A
ROA(3y)-3.87%
ROA(5y)-1.91%
ROE(3y)-6.6%
ROE(5y)-3.34%
ROIC(3y)N/A
ROIC(5y)N/A
1AVAV.MI Yearly ROA, ROE, ROIC1AVAV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Profit Margin of 1AVAV has declined.
1AVAV's Operating Margin has declined in the last couple of years.
1AVAV has a Gross Margin (30.60%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 1AVAV has remained more or less at the same level.
1AVAV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.6%
OM growth 3YN/A
OM growth 5Y-10.88%
PM growth 3YN/A
PM growth 5Y-13.83%
GM growth 3Y7.02%
GM growth 5Y-1.41%
1AVAV.MI Yearly Profit, Operating, Gross Margins1AVAV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

1AVAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1AVAV has more shares outstanding
The number of shares outstanding for 1AVAV has been increased compared to 5 years ago.
Compared to 1 year ago, 1AVAV has a worse debt to assets ratio.
1AVAV.MI Yearly Shares Outstanding1AVAV.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
1AVAV.MI Yearly Total Debt VS Total Assets1AVAV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

1AVAV has an Altman-Z score of 7.65. This indicates that 1AVAV is financially healthy and has little risk of bankruptcy at the moment.
1AVAV has a Altman-Z score of 7.65. This is amongst the best in the industry. 1AVAV outperforms 93.48% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that 1AVAV is not too dependend on debt financing.
1AVAV has a Debt to Equity ratio of 0.16. This is amongst the best in the industry. 1AVAV outperforms 91.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 7.65
ROIC/WACCN/A
WACC9.78%
1AVAV.MI Yearly LT Debt VS Equity VS FCF1AVAV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

1AVAV has a Current Ratio of 5.96. This indicates that 1AVAV is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.96, 1AVAV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
1AVAV has a Quick Ratio of 5.12. This indicates that 1AVAV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of 1AVAV (5.12) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.96
Quick Ratio 5.12
1AVAV.MI Yearly Current Assets VS Current Liabilites1AVAV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

1AVAV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.53%.
1AVAV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.43% yearly.
1AVAV shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.04%.
1AVAV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.44% yearly.
EPS 1Y (TTM)-7.53%
EPS 3Y38.53%
EPS 5Y12.43%
EPS Q2Q%-64.04%
Revenue 1Y (TTM)44.04%
Revenue growth 3Y22.57%
Revenue growth 5Y17.44%
Sales Q2Q%139.96%

3.2 Future

1AVAV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.53% yearly.
1AVAV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.44% yearly.
EPS Next Y4.96%
EPS Next 2Y18.57%
EPS Next 3Y24.17%
EPS Next 5Y24.53%
Revenue Next Year153.96%
Revenue Next 2Y71.56%
Revenue Next 3Y50.54%
Revenue Next 5Y34.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1AVAV.MI Yearly Revenue VS Estimates1AVAV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
1AVAV.MI Yearly EPS VS Estimates1AVAV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 105.57 indicates a quite expensive valuation of 1AVAV.
Based on the Price/Earnings ratio, 1AVAV is valued a bit more expensive than the industry average as 69.57% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.38, 1AVAV is valued quite expensively.
With a Price/Forward Earnings ratio of 61.99, 1AVAV can be considered very expensive at the moment.
73.91% of the companies in the same industry are cheaper than 1AVAV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 1AVAV to the average of the S&P500 Index (22.86), we can say 1AVAV is valued expensively.
Industry RankSector Rank
PE 105.57
Fwd PE 61.99
1AVAV.MI Price Earnings VS Forward Price Earnings1AVAV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1AVAV is valued more expensive than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 159.91
1AVAV.MI Per share data1AVAV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as 1AVAV's earnings are expected to grow with 24.17% in the coming years.
PEG (NY)21.27
PEG (5Y)8.49
EPS Next 2Y18.57%
EPS Next 3Y24.17%

More info and screens

0

5. Dividend

5.1 Amount

1AVAV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AEROVIRONMENT INC

BIT:1AVAV (9/19/2025, 7:00:00 PM)

242.8

+28.8 (+13.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-09 2025-09-09/amc
Earnings (Next)12-02 2025-12-02
Inst Owners58.92%
Inst Owner ChangeN/A
Ins Owners0.77%
Ins Owner ChangeN/A
Market Cap12.12B
Analysts86.32
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.85%
Min EPS beat(2)-15.12%
Max EPS beat(2)13.42%
EPS beat(4)1
Avg EPS beat(4)-22.68%
Min EPS beat(4)-53.02%
Max EPS beat(4)13.42%
EPS beat(8)5
Avg EPS beat(8)22.51%
EPS beat(12)6
Avg EPS beat(12)27.47%
EPS beat(16)8
Avg EPS beat(16)8.87%
Revenue beat(2)2
Avg Revenue beat(2)6.52%
Min Revenue beat(2)1.43%
Max Revenue beat(2)11.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-16.31%
Max Revenue beat(4)11.62%
Revenue beat(8)7
Avg Revenue beat(8)1.4%
Revenue beat(12)10
Avg Revenue beat(12)3.34%
Revenue beat(16)11
Avg Revenue beat(16)0.86%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)7.94%
EPS NQ rev (3m)-22.84%
EPS NY rev (1m)1.7%
EPS NY rev (3m)-20.34%
Revenue NQ rev (1m)-1.11%
Revenue NQ rev (3m)87.38%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)86.29%
Valuation
Industry RankSector Rank
PE 105.57
Fwd PE 61.99
P/S 13.1
P/FCF N/A
P/OCF N/A
P/B 3.21
P/tB 18.51
EV/EBITDA 159.91
EPS(TTM)2.3
EY0.95%
EPS(NY)3.92
Fwd EY1.61%
FCF(TTM)-3.46
FCFYN/A
OCF(TTM)-2.62
OCFYN/A
SpS18.53
BVpS75.55
TBVpS13.12
PEG (NY)21.27
PEG (5Y)8.49
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.6%
FCFM N/A
ROA(3y)-3.87%
ROA(5y)-1.91%
ROE(3y)-6.6%
ROE(5y)-3.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-10.88%
PM growth 3YN/A
PM growth 5Y-13.83%
GM growth 3Y7.02%
GM growth 5Y-1.41%
F-Score1
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 8.13
Cap/Depr 40.4%
Cap/Sales 4.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.96
Quick Ratio 5.12
Altman-Z 7.65
F-Score1
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)46.34%
Cap/Depr(5y)46.82%
Cap/Sales(3y)2.98%
Cap/Sales(5y)3.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.53%
EPS 3Y38.53%
EPS 5Y12.43%
EPS Q2Q%-64.04%
EPS Next Y4.96%
EPS Next 2Y18.57%
EPS Next 3Y24.17%
EPS Next 5Y24.53%
Revenue 1Y (TTM)44.04%
Revenue growth 3Y22.57%
Revenue growth 5Y17.44%
Sales Q2Q%139.96%
Revenue Next Year153.96%
Revenue Next 2Y71.56%
Revenue Next 3Y50.54%
Revenue Next 5Y34.44%
EBIT growth 1Y-147.59%
EBIT growth 3YN/A
EBIT growth 5Y4.66%
EBIT Next Year303.52%
EBIT Next 3Y84.48%
EBIT Next 5Y55.2%
FCF growth 1Y-485.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-611.81%
OCF growth 3YN/A
OCF growth 5YN/A